Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394706 · ClinicalTrials.gov registry record · Phase 3
Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve
A Phase 3 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 3
- Development phase
- 11,738
- Enrollment target
NCT00394706: Clinical Trial Phase 3 study, sponsored by University of Washington.
NCT00394706 is a Phase 3 study that was terminated before completion, run by University of Washington. The registered enrollment target is 11,738 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1422% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394706, a Phase 3 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 11,738 participants
- Enrollment target
Study Summary
The purpose of this study is to look at two different treatments during a cardiac arrest that occurs outside of the hospital and whether either or both treatments will increase the number of people who live to hospital discharge. A cardiac arrest is when the heart stops pumping blood to the body.
Primary Outcome
The modified Rankin Score (mRS) measures the ability of patients to function independently. The scale goes from 0 (no symptoms) to 6 (death). Subjects with a mRS scores of three or less (i.e. better) at the time of hospital discharge were considered to have a positive outcome, resulting in a binary measure.
Interventions
- DEVICE Impedance Threshold Device (ITD)
- DEVICE Sham ITD
- OTHER Analyze early
- OTHER Analyze later
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,738 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Why NCT00394706 stopped before completion
NCT00394706 is an interventional study that assigns participants to a tested intervention. Its 11,738 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1422% higher).
The record links to 0 conditions, and to 4 interventions - of which Impedance Threshold Device (ITD) is the first listed.
NCT00394706 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00394706 about?
NCT00394706 is a clinical study titled "Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve". The purpose of this study is to look at two different treatments during a cardiac arrest that occurs outside of the hospital and whether either or both treatments will increase the number of people who live to hospital discharge. A cardiac arrest is when the heart stops pumping blood to the body.
What is the current status of trial NCT00394706?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 11,738 participants. The study started on 2007-06. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00394706?
The interventions under investigation include: Impedance Threshold Device (ITD) (DEVICE), Sham ITD (DEVICE), Analyze early (OTHER), Analyze later (OTHER).
Who is sponsoring clinical trial NCT00394706?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00394706's enrollment target sits among peer trials
11,738 21st of 2000 higher than 1,980 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07064473 · 11,800 participants · Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia